We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
+11.01%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$54B
AUM Growth
+$14.5B
(+37%)
Cap. Flow
+$10.7B
Cap. Flow
% of AUM
19.86%
Top 10 Holdings %
Top 10 Hldgs %
63.09%
Holding
166
New
21
Increased
55
Reduced
22
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$285M |
| 2 |
Pinterest
PINS
|
+$235M |
| 3 |
CoStar Group
CSGP
|
+$221M |
| 4 |
Meta Platforms (Facebook)
META
|
+$181M |
| 5 |
TJX Companies
TJX
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$242M |
| 2 |
Mercado Libre
MELI
|
+$165M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$164M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
+$94.8M |
| 5 |
Boeing
BA
|
+$91.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.16% |
| 2 | Consumer Discretionary | 7.33% |
| 3 | Communication Services | 3.81% |
| 4 | Financials | 3.2% |
| 5 | Healthcare | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Monolithic Power Systems
MPWR
$67.9B
| $8.39M | 0.02% |
+30,000
| New | +$7.81M |
|
127
Oric Pharmaceuticals
ORIC
$1.41B
| $7.58M | 0.01% |
+303,061
| New | +$7.21M |
|
128
Cytokinetics
CYTK
$10.5B
| $6.5M | 0.01% |
300,000
+50,000
| +20% | +$1.17M |
|
129
Denali Therapeutics
DNLI
$4B
| $5.73M | 0.01% |
160,000
+60,000
| +60% | +$1.81M |
|
130
PUT
Equity Residential
EQR
$24.7B
| $5.13M | 0.01% |
+100,000
| New | +$5.53M |
|
|
MORF
131
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $4.1M | 0.01% |
150,000
+50,000
| +50% | +$1.31M |
|
132
GDS Holdings
GDS
$6.29B
| $2.46M | ﹤0.01% |
30,000
-60,000
| -67% | -$4.81M |
|
133
Neurogene
NGNE
$729M
| $2.4M | ﹤0.01% |
10,000
| – | – |
|
134
Keros Therapeutics
KROS
$212M
| $1.16M | ﹤0.01% |
30,000
| – | – |
|
135
Costco
COST
$423B
| $966K | ﹤0.01% |
2,722
| – | – |
|
136
Alector
ALEC
$189M
| $632K | ﹤0.01% |
60,000
| – | – |
|
137
Agios Pharmaceuticals
AGIO
$1.95B
| – | – |
-491,615
| Closed | -$26.3M |
|
138
CALL
Amazon
AMZN
$3T
| – | – |
-2,500,000
| Closed | -$345M |
|
|
API
139
Agora
API
$386M
| – | – |
-400,000
| Closed | -$17.7M |
|
|
140
Boeing
BA
$184B
| – | – |
-500,876
| Closed | -$91.8M |
|
141
BJs Wholesale Club
BJ
$12.3B
| – | – |
-175,000
| Closed | -$6.52M |
|
142
Dianthus Therapeutics
DNTH
$6.25B
| – | – |
-37,500
| Closed | -$4.51M |
|
|
DOCU
143
DocuSign
DOCU
$11.4B
| – | – |
-30,000
| Closed | -$6.23M |
|
144
Elastic
ESTC
$7.93B
| – | – |
-435,824
| Closed | -$40.2M |
|
145
CALL
Intel
INTC
$492B
| – | – |
-1,000,000
| Closed | -$59.8M |
|
146
CALL
Lyft
LYFT
$6.55B
| – | – |
-1,100,000
| Closed | -$36.3M |
|
|
147
CALL
Mercado Libre
MELI
$92.5B
| – | – |
-125,000
| Closed | -$123M |
|
148
Passage Bio
PASG
$13.9M
| – | – |
-25,250
| Closed | -$13.8M |
|
149
CALL
RTX Corp
RTX
$302B
| – | – |
-1,000,000
| Closed | -$61.6M |
|
150
Sol-Gel Technologies
SLGL
$277M
| – | – |
-11,200
| Closed | -$1M |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Alkeon Capital Management held 166 positions worth $54B, up 37% from $39.5B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Alkeon Capital Management deployed $10.7B of net new capital in Q3 2020, opening 21 new positions and adding to 55 existing holdings. Its largest new stake was Salesforce: 1,300,000 shares worth $327M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Apple, an estimated $242M trimmed.
- Alkeon Capital Management's largest Q3 2020 buy was Salesforce: 1,300,000 shares worth $327M.
- Alkeon Capital Management added most to CoStar Group in Q3 2020, an estimated $221M increase.
- Alkeon Capital Management's biggest Q3 2020 reduction was Apple, cutting an estimated $242M.
- Alkeon Capital Management fully exited Immunomedics Inc in Q3 2020, selling an estimated $164M.
- Alkeon Capital Management's ten largest holdings make up 63% of its $54B portfolio in Q3 2020.
- Alkeon Capital Management opened 21 new positions and closed 21 in Q3 2020.
- Alkeon Capital Management's portfolio value rose 37% quarter-over-quarter to $54B.
Based on Alkeon Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.